BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17145872)

  • 1. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
    Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
    Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
    Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
    Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
    Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
    Billottet C; Tuefferd M; Gentien D; Rapinat A; Thiery JP; Broët P; Jouanneau J
    J Cell Biochem; 2008 Jun; 104(3):826-39. PubMed ID: 18189245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal to epithelial transition in development and disease.
    Chaffer CL; Thompson EW; Williams ED
    Cells Tissues Organs; 2007; 185(1-3):7-19. PubMed ID: 17587803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
    Vincan E; Brabletz T; Faux MC; Ramsay RG
    Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
    De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
    Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases.
    Thomas-Mudge RJ; Okada-Ban M; Vandenbroucke F; Vincent-Salomon A; Girault JM; Thiery JP; Jouanneau J
    Oncogene; 2004 Jun; 23(27):4771-9. PubMed ID: 15122340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents.
    Vargha R; Endemann M; Kratochwill K; Riesenhuber A; Wick N; Krachler AM; Malaga-Dieguez L; Aufricht C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2943-7. PubMed ID: 16861732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
    Li GC; Wang ZY
    Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
    Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
    Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
    Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.